GE HealthCare Technologies Inc.

GE HealthCare Technologies Inc. develops, manufactures, and markets products, services, and digital solutions used in the diagnosis, treatment, and monitoring of patients globally. Its operations are structured into four segments: Imaging, Advanced Visualization Solutions (AVS), Patient Care Solutions (PCS), and Pharmaceutical Diagnostics (PDx). The Imaging segment offers molecular imaging, CT scanning, MR imaging, X-ray systems, and women's health products. AVS provides ultrasound and image-guided therapies. PCS includes patient monitoring, diagnostic cardiology, and anesthesia products. PDx supplies contrast media and molecular imaging agents used prior to diagnostic scans.

GE HealthCare Technologies Inc. is listed on the NasdaqGS exchange under the ticker symbol GEHC. Its financials are reported in US Dollars (USD), reflecting its primary listing in the United States. The company is headquartered in the United States and operates in the US region, making USD its functional currency for reporting and transactions.

GE HealthCare Technologies Inc. operates in the Healthcare sector, specifically within the Medical Devices industry. This means the company focuses on developing and manufacturing medical equipment and technologies used by healthcare providers for diagnosis, treatment, and patient monitoring. Its products range from imaging systems like CT and MRI scanners to ultrasound devices, patient monitoring systems, and diagnostic pharmaceuticals.

GE HealthCare Technologies Inc. is headquartered in the United States and serves a global market. The company's description indicates it markets its products, services, and digital solutions worldwide. While specific headquarters city is not provided, its country is the United States, and its region is designated as 'us'. The company's global reach is evident from its four operating segments that cater to healthcare providers across various countries.

GE HealthCare Technologies generates revenue through four main segments. The Imaging segment sells molecular imaging, CT, MR, X-ray, and women's health systems. The Advanced Visualization Solutions (AVS) segment provides ultrasound and image-guided therapy products. Patient Care Solutions (PCS) offers patient monitoring, diagnostic cardiology, maternal infant care, and anesthesia devices, along with consumables and digital solutions. The Pharmaceutical Diagnostics (PDx) segment supplies contrast media and radiopharmaceuticals used in imaging procedures. This diversified portfolio allows the company to earn from equipment sales, consumables, services, and diagnostic agents.